Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety Study of V0114CP 2.5 mg in Seasonal Allergic Rhinitis
2008-001860-36Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing V0114CP 2.5 mg (desloratadine) with Placebo (2 arms). Started Apr 2008; status: completed.
02
Drugs
desloratadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2008-001860-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001860-36.